Acceptance rate:
Time to first decision with review (median):
35 days*
Time to first decision without review (median):
5 days*
Acceptance to publication:
21 days*
Impact Factor (JCR):
Total content views:

Aims and scope

The International Journal of Gynecological Cancer, the official journal of the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology, is the primary educational and informational publication for topics relevant to detection, prevention, diagnosis, and treatment of gynecologic malignancies. IJGC emphasizes a multidisciplinary approach, and includes original research, reviews, and video articles. The audience consists of gynecologists, medical oncologists, radiation oncologists, radiologists, pathologists, and research scientists with a special interest in gynecological oncology. For information about International Journal of Gynecological Cancer Editor-in-Chief Pedro T. Ramirez and his editorial team, please refer to the Editorial Board page.

Plan S compliance

The International Journal of Gynecological Cancer is a Plan S compliant Transformative Journal. Transformative Journals are one of the compliance routes offered by cOAlition S funders, such as Wellcome, WHO and UKRI. Find out more about Transformative Journals and Plan S compliance on our Author Hub.


IJGC is owned by the International Gynecological Cancer Society and the European Society of Gynaecological Oncology. The International Gynecologic Cancer Society (IGCS) is a not-for-profit independent organization contributing to the prevention, treatment and study of gynecologic cancer, as well as improvement in the quality of life among women suffering from gynecologic cancer throughout the world. The European Society of Gynaecological Oncology (ESGO) is the principal organization in Europe contributing to the study, prevention and treatment of gynaecological cancer. ESGO has members in over 30 countries in Europe.

Journal information

IJGC is owned by the International Gynecological Cancer Society and the European Society of Gynaecological Oncology.
Publication Model
Online ISSN
Launch Date
Digital Archives
Indexed by
Web of Science Core Collection: Science Citation Index; Science Citation Index Expanded, Medline (Index Medicus), Current Contents: Clinical Medicine, PubMed Central (BMJ Open Access Special Collection), Scopus, Embase (Excerpta Medica), CAB Abstracts, Derwent
Peer Review Model
Single anonymised; the names of reviewers are hidden from the author

Journal Statistics 2023

Acceptance rate: 40%
Speed Time to first decision without review: 5 days (median) Time to first decision with review: 35 days (median) Time from acceptance to publication: 21 days (median)
Impact Impact Factor category: Obstetrics & Gynecology Impact Factor (JCR): 4.8 Impact Factor rank: 13/85 5 Year Impact Factor: 4.0 Journal Citation Indicator:1.21 Eigenfactor: 0.01103 Citescore: 6.7 Citescore rank: 18/197 Scimago Journal Rank (SJR): 1.134
Reach Total content views: 513,584 Total Altmetric mentions: 2,193
the SF Dora logo
The impact that academic research has cannot be defined by one single metric. In 2013, BMJ signed the San Francisco Declaration on Research Assessment (DORA). We did this to show our support for using multiple measures and metrics to portray journals’ impact; moving away from the Impact Factor as a single measure. How we get these metrics


Online advertising – USA and Canada only
Jim Cunningham jcunningham@cunnasso.com Tel: +1 201.767.4170 Fax: +1 201.767.8065 Information on rates
Online advertising – All countries except USA and Canada


IJGC logo
The mission of the International Gynecologic Cancer Society is to enhance the care of women with gynecologic cancer worldwide through education and training and public awareness.
ESGO logo
The mission of the European Society of Gynaecological Oncology is to improve the health and well-being of European women with gynaecological (genital and breast) cancers through prevention, excellence in care, high quality research and education.
COPE logo
BMJ is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.
The EQUATOR Network is an international initiative that seeks to improve the value of medical research literature by promoting transparent, accurate reporting of research studies. BMJ is a sponsor of its activities.
AllTrials logo
BMJ is a founding organisation of the AllTrials initiative, which calls for all past and present clinical trials to be registered and their results reported.
ICMJE logo
The ICMJE is a small working group of general medical journal editors whose participants meet annually and fund their own work on the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals. The ICMJE invites comments on this document and suggestions for agenda items. The current members of the ICMJE are Annals of Internal Medicine, The BMJ, Bulletin of the World Health Organization, Deutsches Ärzteblatt (German Medical Journal, Ethiopian Journal of Health Sciences, Iranian Journal of Medical Sciences, JAMA (Journal of the American Medical Association), Journal of Korean Medical Science, New England Journal of Medicine, New Zealand Medical Journal, PLOS Medicine, The Lancet, Revista Médica de Chile (Medical Journal of Chile), Ugeskrift for Laeger (Danish Medical Journal), the U.S. National Library of Medicine, and the World Association of Medical Editors.